Singapore markets open in 6 hours 7 minutes

Aura Biosciences, Inc. (AURA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
7.56+0.28 (+3.85%)
At close: 04:00PM EDT
7.56 0.00 (0.00%)
After hours: 04:10PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 373.06M
Enterprise value 189.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)1.79
Enterprise value/revenue N/A
Enterprise value/EBITDA -5.68

Trading information

Stock price history

Beta (5Y monthly) 0.36
52-week change 3-38.49%
S&P500 52-week change 322.55%
52-week high 312.50
52-week low 35.99
50-day moving average 37.30
200-day moving average 38.12

Share statistics

Avg vol (3-month) 3170.64k
Avg vol (10-day) 3299.88k
Shares outstanding 549.54M
Implied shares outstanding 649.54M
Float 830.85M
% held by insiders 17.53%
% held by institutions 179.16%
Shares short (14 Jun 2024) 42.89M
Short ratio (14 Jun 2024) 414.84
Short % of float (14 Jun 2024) 47.91%
Short % of shares outstanding (14 Jun 2024) 45.82%
Shares short (prior month 15 May 2024) 42.7M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-24.90%
Return on equity (ttm)-40.43%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -86.59M
Net income avi to common (ttm)-78.65M
Diluted EPS (ttm)-1.87
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)202.87M
Total cash per share (mrq)4.09
Total debt (mrq)19.32M
Total debt/equity (mrq)9.25%
Current ratio (mrq)21.97
Book value per share (mrq)4.22

Cash flow statement

Operating cash flow (ttm)-71.89M
Levered free cash flow (ttm)-46.54M